REGULATORY AGENCY ACTION
cycle to a cyclical renewal cycle. The Board
further decided to set up a procedure for
annual review of its Executive Officer.
Also at BENHA's October 19 meeting,
DCA Director Jim Conran addressed the
Board; among other things, Conran noted
that the Board's function is to protect the
public by ensuring that its licensees maintain quality standards and that problems
are looked at fairly, honestly, and expeditiously, particularly if there is a health and
safety concern. Conran reminded the
Board that effective January 1, the Board
will have interim suspension authority
under SB 842 (Presley) (Chapter 840,
Statutes of 1993), which will allow the
Board to immediately suspend a license
pending conclusion of the formal discipline process, which can take up to three
years. [13:4 CRLR 76] Conran concluded
his remarks by stating that the DCA has
confidence in the Board and offered
DCA's assistance in the Board's effort to
move forward.
On November 30, BENHA held a strategic planning session in Los Angeles. The
public was invited to attend the meeting,
but was not allowed to offer comment or
testimony. The purpose of the session was
to establish Board priorities for 1994-96;
it was not a decisionmaking meeting.
Among the issues considered at this meeting
were the possibility of adding a committee
to exclusively address licensing issues; residential care for the elderly; changing the
Board's enabling act to refer to the Board
President and Vice-President instead of
Chairman and Vice Chairman; whether
BENHA should establish a pool of qualified
preceptor trainers and/or enter into a formal
contract with the America College of Nursing Home Administrators; BENHA's complaint disclosure policy; the need to review
current policy specific to citations issued by
DHS; the possibility of utilizing DOI's investigative services to improve its enforcement program; the possibility of developing
a pool of qualified expert witnesses for case
evaluation; and the establishment of a citation and fine program.
*

FUTURE MEETINGS
April 21 in Los Angeles.
July 21 in Sacramento.
October 27 in San Diego.

BOARD OF OPTOMETRY
Executive Officer: Karen Ollinger
(916) 323-8720

p

ursuant to Business and Professions
Code section 3000 et seq., the Board
of Optometry is responsible for licensing

qualified optometrists and disciplining
malfeasant practitioners. The Board establishes and enforces regulations pertaining
to the practice of optometry, which are
codified in Division 15, Title 16 of the
California Code of Regulations (CCR).
The Board's goal is to protect the consumer patient who might be subjected to
injury resulting from unsatisfactory eye
care by inept or untrustworthy practitioners. The Board consists of nine members-six licensed optometrists and three
public members.
Kenneth H. Woodard, OD, resigned
from the Board in November. Woodard,
the first corporate optometrist to be appointed to the Board, had only served one
year of his term.

U

MAJOR PROJECTS
Board Rejects Proposed Change to
Licensure Exam. At its December meeting, the Board considered whether to administer the National Board of Examiners
in Optometry's (NBEO) Part III examination instead of the California clinical competency examination. Presently, applicants must successfully complete Parts I
and II of the NBEO examination before
they are permitted to take the California
examination; both parts of the NBEO
exam and the California exam must be
passed before an individual is licensed to
practice optometry in California.
Those who favor use of the NBEO Part
III exam as a substitute for the Board's
exam argue that the NBEO is a more consistent method of testing applicants; the
test is very uniform in its assessment of
knowledge of pathology, clinical skills,
and patient management; on the clinical
section, candidates are not required to participate as patients for other candidates (as
they must in the California exam), thus
preventing the severe and costly implications which may arise if a candidate
is accidentally injured while serving as a
patient or the candidate serving as the
patient is not cooperative; and adoption of
the exam would save the Board time and
money which would be better spent on
enforcement. Proponents generally argue
that there is nothing uniquely "California"
about the practice of optometry which requires a state-specific clinical competency
exam, and that use of an established standardized exam is thus appropriate. About
25 states administer Part III of the NBEO
instead of their own clinical exam.
The California Optometric Association (COA) expressed support for maintaining the California-administered exam,
arguing that the Board's exam is now adequately funded by examination fees; the
Board's staff may be cut if it ceases admin-
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istering its own exam; the Board's exam is
offered at a much lower cost to the applicant ($275 compared to $700); the NBEO
exam does not provide an appeals process,
whereas the Board permits examinees to
appeal a failing grade (although the Board
attempted unsuccessfully last year to abolish its appeals process) [13:1 CRLR 59];
and the results of the Board's exam are
available twice as fast as the NBEO, thus
allowing successful applicants to begin
practicing months earlier. COA also contended that the Board would be risking its
independent existence if it eliminates its
clinical competency exam; COA noted
that if the only function of the Board is to
enforce the laws governing optometry, the
legislature may decide that such enforcement activities could be combined with
the enforcement activities of other health
care boards-perhaps resulting in the
placement of optometry within a "superboard" that may be "medically dominated."
Following discussion, the Board agreed
to continue its administration of the California exam instead of NBEO's Part III
exam.
Occupational Analysis Completed.
At the Board's December 1 meeting,
HRStrategies (HRS) presented its occupational analysis of the practice of optometry. Since January 1993, HRS has been
conducting a comprehensive occupational
analysis of the profession in order in order
to precisely identify the knowledge, skills,
and abilities (KSAs) of licensed optometrists currently practicing in California.
The analysis will be used to evaluate the
Board's current licensing examination to
ensure that it is testing relevant KSAs.
113:4 CRLR 79; 13:1 CRLR 59]
The final analysis presented 75 different task statements, each identifying a particular aspect or requirement of the practice of optometry. For example, the analysis identified the following tasks performed by optometrists: questioning patients or caregivers either verbally or with
a written questionnaire to retrieve relevant
information for proper diagnosis and/or
treatment; testing patients using ophthalmic equipment and optometric tests to
gather general information; refracting patients to achieve the proper prescription
for glasses by using a phoropter/auto refractor; performing trial fitting or framing
of tentative prescriptions using trial
frames and/or trial lenses in order to determine proper contact lens and/or glasses
prescriptions; examining patients to evaluate ocular health; performing or ordering
lab tests; and observing ocular structure to
assess variations from normal using pharmaceutical agents (dilating drops).
7

REGULATORY AGENCY ACTION
The Board now plans to compare the
results of the occupational analysis with
its existing examination.
Regulatory Changes on Disclosure of
Contact Lens Prescription Release Policy
and Delegation of Functions Await Approval. At its August meeting, the Board
adopted proposed amendments to section
1502 and the addition of new section 1566,
Title 16 of the CCR. The amendments to
section 1502 would delegate and confer
solely upon the Board's Executive Officerinstead of upon the Board Secretary--enforcement-related functions involving the
filing of accusations, issuing notices of hearings, statements to respondents, statements
of issues, and other powers and duties conferred by law on the Board. New section
1566 would require each optometry office to
post in a conspicuous place a notice which
clearly states the legal requirements and office policy regarding the release of spectacle
and contact lens prescriptions. The Board
approved section 1566 on a 4-2 vote over
the objection of COA, which argued that the
notice requirement would be "overly burdensome" and that no other profession has
such a requirement (although physicians
routinely hand patients their prescriptions,
enabling patients to fill their prescriptions at
the pharmacy of their choice). [13:4 CRLR
771
Although the Board modified the language of section 1566 slightly, it considered the modifications to be so minor that
they do not require an additional fifteenday public comment period. On December
9, the Board submitted the proposed regulatory changes to the Department of Consumer Affairs for review and approval; if
approved, the rulemaking file will then be
forwarded to the Office of Administrative
Law for review and approval.

U

LEGISLATION
Future Legislation. At its December
meeting, the Board voted to sponsor two
legislative proposals in 1994. First, the
Board decided to seek the repeal of Business and Professions Code section 3025.6,
which requires the Board to provide notice
and a reasonable opportunity for compliance to a licensee who has violated the
Board's regulations before it may institute
disciplinary action. Second, the Board
voted to support legislation allowing it to
impose discipline against a licensee based
solely on disciplinary action taken by another state.
AB 2020 (Isenberg), as amended June
17, would provide that the practice of optometry includes, among other things, the
examination of the human eye, or its appendages and adnexa, and the analysis and
diagnosis of conditions of the human vi'2

sion system, either subjectively or objectively. This bill would delete an existing
requirement that the Board designate pharmaceutical agents which may be used by
optometrists in examining the human eye
and instead authorize the use of specified
diagnostic pharmaceutical agents. It would
also authorize the use, prescribing, and dispensing of specified therapeutic pharmaceutical agents to a patient by an optometrist for
the purposes of treating the human eye, or its
appendages or adnexa, for any disease or
pathological condition by an optometrist
who meets specified requirements. The bill
would establish a seven-member pharmaceutical advisory committee with a prescribed membership to provide advice to the
Board as to the use of diagnostic and therapeutic agents. Under this bill, only optometrists who meet several examination and
training requirements and agree to accept
Medi-Cal patients are permitted to use, dispense, or prescribe therapeutic pharmaceutical agents. AB 2020 would also make it a
misdemeanor for any person licensed as an
optometrist to refer a patient to a pharmacy
that is owned by the licensee or in which the
licensee has a proprietary interest. This bill,
which is sponsored by COA and opposed by
the California Medical Association, was rejected on June 28 but granted reconsideration. [S. B&P]
AB 1807 (Bronshvag). Existing law
provides that a person who has obtained
an optometry degree from a university
located outside the United States, if he/she
meets other specified requirements, may
take the Board's examination for a certificate of registration as an optometrist.
Until January 1, 1994, the Board may
refuse to permit a person to take the examination if it finds that the curriculum of the
institution granting the degree is not reasonably equivalent to that required of applicants who have graduated from an institution within the United States; on January 1, 1994, that authority expires. As
amended September 8, this bill would extend that authority until January 1, 1996.
[13:4 CRLR 77-78]
Existing law provides that, until January 1, 1994, a person who graduated from
a foreign optometry school prior to 1980
and who was previously sponsored or
qualified to be sponsored by the Board for
the NBEO examination, shall be sponsored for the national exam. Upon passing
the national exam, under existing law, the
person is required to be permitted to take
the examination for licensure as an optometrist. This bill would extend the repeal
date until January 1, 1996.
Existing law provides that in most circumstances, a certificate issued by the
Board may be renewed up to five years

after the date of expiration if the applicant
passes the regular examination of the
Board and pays outstanding fees. This bill
would reduce the period for renewal to
three years after the expiration of the certificate, if the person passes the clinical
portion of the regular examination of applicants, or other clinical examination approved by the Board, and pays all outstanding fees. [A. Inactive File]
AB 1894 (Polanco), as introduced
March 5, would authorize ancillary personnel who work under the supervision of
an optometrist to assist in the preparation
of the patient and the preliminary collection of data. The bill would prohibit an
optometrist from permitting ancillary personnel to collect data requiring the exercise of professional judgment or skill of an
optometrist, perform any subjective refraction procedures, contact tonometry,
data analysis, or diagnosis, or prescribe
and determine any treatment plan. [A.
Health]
SB 908 (Calderon), as introduced
March 4, would provide that the terms
"license" and "certificate of registration"
are deemed to be synonymous for the purposes of the provisions of law regarding
the licensure and regulation of optometry.
[A. Health]
SB 921 (Maddy), as introduced March
4, would provide that it is unprofessional
conduct for an optometrist to fail to advise
a patient in writing of any pathology that
requires the attention of a physician when
an examination of the eyes indicates a
substantial likelihood of any pathology.
[S. B&P]
*

LITIGATION
In Engineers and Scientists of California (ESC), et aL v. Division of Allied
Health Professions, Medical Board of
California, No. 532588, ESC and COA
challenge the validity of the medical assistant regulations adopted by the Medical
Board's Division of Allied Health Professions, contending that the regulations permit unlicensed medical assistants to perform optometric tasks and functions.
[13:2&3 CRLR 100] A trial-setting conference scheduled for December 6 was
postponed until January 3; the parties expect a trial date to be set sometime in April.

U

RECENT MEETINGS
At its December meeting, the Board
reviewed its existing complaint disclosure
policy and decided to maintain the current
policy until pending litigation in regard to
the Medical Board's disclosure policy is
resolved. (See agency report on MEDICAL BOARD OF CALIFORNIA for related discussion.)
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REGULATORY AGENCY ACTION
At its December meeting, the Board
vote for President resulted in a tie between
John Anthony, OD, and Pamela Miller,
OD, JD. Because of the tie, existing president Thomas Nagy, OD, will continue to
serve as president until a new vote is taken
at the March meeting. The committee
chairs will also remain the same until
March, as they are selected by the President.
*

FUTURE MEETINGS
March 11-12 in Long Beach.
May 19-20 in San Diego (tentative).

BOARD OF PHARMACY
Executive Officer: PatriciaHarris
(916) 445-5014

p

ursuant to Business and Professions
Code section 4000 et seq., the Board
of Pharmacy grants licenses and permits
to pharmacists, pharmacies, drug manufacturers, wholesalers, and sellers of hypodermic needles. It regulates all sales of
dangerous drugs, controlled substances,
and poisons. The Board is authorized to
adopt regulations, which are codified in
Division 17, Title 16 of the California
Code of Regulations (CCR). To enforce its
regulations, the Board employs full-time
inspectors who investigate complaints received by the Board. Investigations may
be conducted openly or covertly as the
situation demands.
The Board conducts fact-finding and
disciplinary hearings and is authorized by
law to suspend or revoke licenses or permits for a variety of reasons, including
professional misconduct and any acts substantially related to the practice of pharmacy.
The Board consists of ten members,
three of whom are nonlicensees. The remaining members are pharmacists, five of
whom must be active practitioners. All are
appointed for four-year terms.
At the Board's October 6 meeting,
President Raffi Simonian introduced new
Board members Holly Ann Strom and
Gary Dreyfus, appointed by Governor
Wilson on August 19. Strom is drug education coordinator for Kaiser Permanente
in West Los Angeles; Dreyfus is president
of Moulton Plaza Pharmacy in Laguna
Hills, and has fourteen years of experience
as a self-employed pharmacist.

* MAJOR PROJECTS
Board Proposes Regulation on Furnishing to Home Health Agencies. On
December 10, the Board published notice
of its intent to adopt new section 1751.11,
Talifnrnia

Title 16 of the CCR, to establish a list of
dangerous drugs which may be furnished
by a pharmacist to a licensed home health
agency and stored in transportable, tamper-proof, sealed storage containers.
t13:4 CRLR 82] According to the Board,
the drugs on the list are used in parenteral
therapy and do not include controlled substances; the sealed storage container
would be issued by a licensed pharmacy
to a home health agency registered nurse,
who could bring a portable container with
him/her during home care visits to patients. Under the proposed regulation,
drugs could be furnished by the home
health agency registered nurse from the
portable container to patients pursuant to
a prescription or an oral order for emergency treatment or adjustment of parenteral drug therapy; specific administration
protocols would be established regarding
the furnishing of any dangerous drug from
the portable container by the registered
nurse.
Among other things, the regulation
would establish inventory and recordkeeping requirements for the pharmacy
that prepares the containers; require the
home health agency to keep additional
records regarding furnishing; set requirements for the home health agency regarding orally transmitted orders from licensed prescribers to the registered nurse
to authorize furnishing drugs from the
containers; and establish storage requirements to assure that the container is not
exposed to excessive heat or cold which
could damage the contents.
At this writing, the Board is scheduled
to conduct a public hearing on the proposed adoption of section 1751.11 on January 26 in Sacramento.
Citation and Fine Program. On October 6, the Board held a public hearing on
the proposed adoption of new Article 9.5,
commencing with section 1775, Title 16
of the CCR; the new article would implement Business and Professions Code section 125.9 and authorize the Board's Executive Officer to issue citations and fines
for specified violations of law. [13:4
CRLR 79] At the hearing, several individuals and representatives of professional
groups and private pharmacies expressed
opposition to the proposed regulations,
claiming that they fail to provide adequate
due process; delegate powers which only
the Board should exercise; create an adversarial atmosphere between pharmacists and the Board; make it difficult to
determine who to fine (employee or supervisor); lack a statistical showing of need;
provide too broad a range of discretionary
fines; cost too much; do not affect major
violators; present too large a potential to
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clog the system with appeals; preclude
further use of facts if stronger disciplinary
action is needed; and could potentially be
used against a licensee in a civil action.
The Board received other comments in
support of the proposal from individuals
who contended that many of the above
issues could be addressed through modified regulatory language; the legislature
enacted the citation and fine program to
enable agencies to deal with mid-level
problems that do not justify the filing of
an accusation and, although the specific
facts could not be used for further discipline, further action would not be contemplated unless further evidence becomes
available; under the proposed regulations,
licensees would continue to have the full
Administrative Procedure Act appeal process available; the Board could consider
an informal appeal process to the Executive Officer; and the program does not
include an admission of guilt on the
pharmacist's part. Retired Board Supervising Inspector Ken Sain noted that the
citation and fine mechanism is an excellent tool for stopping unlicensed activity,
which often goes unaddressed by district
attorney's offices and other law enforcement agencies which must handle higherpriority matters.
Following discussion, the Board unanimously deferred action on the proposed
regulations and referred the matter to its
Enforcement Committee for further review; specifically, the Board directed the
Enforcement Committee to closely reexamine the proposed regulations, suggest
alternative ways to pursue a citation and
fine program, and-if appropriate-develop the necessary language. The Committee is expected to present its findings
to the Board at a future meeting.
Fee Increases Postponed. Last August, the Board published notice of its
intent to amend sections 1749 and 1793.5,
Title 16 of the CCR, to increase specified
license fees; according to the Board, the
fee increases are necessary to restore the
Board's reserve fund and maintain it at a
prudent level to enable it to conduct ongoing operations. [13:4 CRLR 79] At the
Board's October 6 meeting, Executive Officer Patricia Harris reported new budget
information which indicates that a fee increase will not be needed until July 1995,
and that an increase in fees to the maximum allowed by statute would result in
too high a surplus. Although Department
of Consumer Affairs staff counsel Robert
Miller noted that the Board could consider
adopting the changes with a delayed effective date, the Board unanimously voted to
indefinitely table the proposed fee increases.
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